Androgen deprivation-mediated cytoreduction before interstitial brachytherapy for prostate cancer does not abrogate the elevated risk of urinary morbidity associated with larger initial prostate volume

Brachytherapy

Volumn 6, Issue 4, 2007, Pages 267-271

  Petit, Joshua H ^a   Gluck, Clifford ^a   Kiger III, W S ^a   Laury Henry, D ^a   Karasiewicz, Carol ^a   Talcott, James A ^b   Berg, Solomon ^a   Holupka, Edward J ^a   Kaplan, Irving D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Androgen deprivation; Brachytherapy; Morbidity; Prostate cancer

Indexed keywords

ANDROGEN; BICALUTAMIDE; GOSERELIN; LEUPRORELIN;

AGED; ARTICLE; BRACHYTHERAPY; CATHETERIZATION; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; STATISTICAL SIGNIFICANCE; TUMOR VOLUME; URINE INCONTINENCE;

AGED; ANDROGEN ANTAGONISTS; BRACHYTHERAPY; DYSURIA; HUMANS; MALE; NEOADJUVANT THERAPY; PROSTATE; PROSTATIC NEOPLASMS; RISK; URINARY CATHETERIZATION;

EID: 35648940189     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2007.08.007     Document Type: Article

References (14)

1. Prestidge B.R. Radioisotopic implantation for carcinoma of the prostate: Does it work better than it used to?. Semin Radiat Oncol 8 (1998) 124-132
2. Crook J., McLean M., Catton C., et al. Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation. Int J Radiat Oncol Biol Phys 52 (2002) 453-460
3. Elshaikh M.A., Angermeier K., Ulchaker J.C., et al. Effect of anatomic, procedural, and dosimetric variables on urinary retention after permanent iodine-125 prostate brachytherapy. Urology 61 (2003) 152-155
4. Gelblum D.Y., Potters L., Ashley R., et al. Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. Int J Radiat Oncol Biol Phys 45 (1999) 59-67
5. Hinerman-Mulroy A., Merrick G.S., Butler W.M., et al. Androgen deprivation-induced changes in prostate anatomy predict urinary morbidity after permanent interstitial brachytherapy. Int J Radiat Oncol Biol Phys 59 (2004) 1367-1382
6. Lee N., Wu C.S., Brody R., et al. Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 48 (2000) 1457-1460
7. 125I prostate brachytherapy. Brachytherapy 5 (2006) 9-13
8. Niehaus A., Merrick G.S., Butler W.M., et al. The influence of isotope and prostate volume on urinary morbidity after prostate brachytherapy. Int J Radiat Oncol Biol Phys 64 (2006) 136-143
9. Schwartz D.J., Schild S.E., Wong W.W., et al. Factors associated with the frequency of self-intermittent catheterization after prostate brachytherapy. Int J Radiat Oncol Biol Phys 61 (2005) 60-63
10. Terk M., Stock R.G., and Stone N.N. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol 160 (1998) 1379-1382
11. Wang H., Wallner K., Sutlief S., et al. Transperineal brachytherapy in patients with large prostate glands. Int J Cancer 90 (2000) 199-205
12. Merrick G.S., Butler W.M., Wallner K.E., et al. Effect of transurethral resection on urinary quality of life after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 58 (2004) 81-88
13. Clark J.A., Rieker P., Propert K.J., et al. Changes in quality of life following treatment for early stage prostate cancer. Urology 53 (1999) 161-168
14. Clark J.A., and Talcott J. Symptom indexes to assess outcomes of treatment for early stage prostate cancer. Med Care 39 (2001) 1118-1130